Searchable abstracts of presentations at key conferences in endocrinology

ea0081p172 | Pituitary and Neuroendocrinology | ECE2022

Towards a pituitary apoplexy classification based on clinical presentation and patient journey

Guijt Mathijs , Zamanipoor Najafabadi Amir , Notting Irene , M Pereira Alberto , Verstegen Marco , Biermasz Nienke , van Furth Wouter , Claessen Kim

Purpose: The condition of pituitary apoplexy contains the clinical spectre from life-threatening emergency to a condition with chronic symptoms and self-limiting course, which partly determines diagnostic delay and management. Outcome evaluation of course and management of pituitary apoplexy is hampered by the diverse presentation of this condition and requires appraisal. This study aimed to describe the patient journey, clinical presentation and management of various types of...

ea0099rc5.1 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Clinical use of 18F-fluoro-ethyl-tyrosine PET co-registered with MRI for diagnostic dilemmas in prolactinoma

van Trigt Victoria , Bakker Leontine , Lu Ling , Pelsma Iris , Verstegen Marco , van Furth Wouter , Arias-Bouda Lenka Pereira , Biermasz Nienke

Purpose : To assess the utility of (18F)fluoroethyl-L-tyrosine PET co-registered with magnetic resonance imaging (FET-PET/MRICR) in patients with difficult-to-localize prolactinoma to inform clinical decision making and treatment planning.Methods: Retrospective cohort study of 17 consecutive patients with difficult-to-localize prolactinoma undergoing FET-PET/MRICR between October 2020 and Amgust 2022 for either (1) additional inform...

ea0070aep1076 | Hot topics (including COVID-19) | ECE2020

Outcome squares integrating efficacy and safety, as applied to functioning pituitary adenoma surgery

de Vries Friso , Lobatto Daniel , Verstegen Marco , Schutte Pieter , Notting Irene , Kruit Mark , Ahmed Fasial , Pereira Alberto M , van Furth Wouter , Biermasz Nienke

Background: Transsphenoidal surgery is standard care in the treatment of hormone-secreting pituitary adenomas. Current clinician-reported surgical outcome measures are one-dimensional, typically focussing primarily on complete or partial resection and secondarily on complication rates. However, outcomes are best reflected by the delicate balance of efficacy and complications at patient level. This study proposes a novel way to classify outcome, integrating efficacy and safety ...

ea0056gp202 | Pituitary Clinical | ECE2018

Endoscopic vs microscopic transsphenoidal surgery for Cushing’s disease: a systematic review and meta-analysis

Broersen Leonie H A , Biermasz Nienke R , van Furth Wouter R , de Vries Friso , Verstegen Marco J T , Dekkers Olaf M , Pereira Alberto M

Background: Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma, resulting in glucocorticoid excess. First-choice treatment is transsphenoidal pituitary surgery, using either a microscopic or endoscopic technique. Convincing evidence supporting the choice for one of both techniques, either based on treatment results or complication rate, is lacking.Objective: We aimed to compare endoscopic and microscopic...